Oral Muscle Relaxants for the Treatment of Chronic Pain Associated with Cerebral Palsy.

作者: Omar Viswanath , Elyse M Cornett , Alan D Kaye , Ivan Urits , Amnon A Berger

DOI:

关键词:

摘要: Purpose of review This is a comprehensive literature the available for treatment oral muscle relaxants cerebral palsy (CP) and associated chronic pain. It briefly describes background etiology pain in CP proceeds to weigh evidence relaxants. Recent findings permanent, chronic, non-progressive neuromuscular neurocognitive disorder motor dysfunction that diagnosed infancy frequently (62% patients) accompanied by or recurrent muscular Treatment crucial, focuses mostly on spasticity through non-interventional techniques, surgery medical treatment. Botulinum toxin injections provide temporary denervation, at cost repeated needle sticks. More recently, use has gained ground more are evaluate its efficacy. Common include baclofen, dantrolene diazepam. Baclofen commonly prescribed CP; however, despite year-long experience, there little support from controlled trials mixed. Dantrolene been used 30 years, very current exists use. Its efficacy usually impacted non-adherence due difficult dosing side-effects. Diazepam, benzodiazepine carries risks CNS depression as well addiction abuse. Evidence supporting dated, but recent short-term control enabling non-pharmacological interventions achieve long term benefit would otherwise not be tolerated. options cyclobenzaprine tizanidine. Cyclobenzaprine significant adverse events profile, including sedation; it was found effective, possible effective diazepam, currently FDA approved CP-related further required Tizanidine shown handful small studies. Summary Muscle an important adjunct therapy crucial pain, participation other forms treatments. exist their use, without risk research highlight proper dosing, co-treatments patient selection.

参考文章(32)
KJERSTI RAMSTAD, REIDUN JAHNSEN, OLA H SKJELDAL, TROND H DISETH, Characteristics of recurrent musculoskeletal pain in children with cerebral palsy aged 8 to 18 years. Developmental Medicine & Child Neurology. ,vol. 53, pp. 1013- 1018 ,(2011) , 10.1111/J.1469-8749.2011.04070.X
Susan Ronan, Joan T. Gold, Nonoperative management of spasticity in children. Childs Nervous System. ,vol. 23, pp. 943- 956 ,(2007) , 10.1007/S00381-007-0396-4
Henry O. Marsh, Diazepam in Incapacitated Cerebral-Palsied Children JAMA: The Journal of the American Medical Association. ,vol. 191, pp. 797- 800 ,(1965) , 10.1001/JAMA.1965.03080100015003
Anna Mathew, M. C. Mathew, Molly Thomas, B. Antonisamy, The Efficacy of Diazepam in Enhancing Motor Function in Children with Spastic Cerebral Palsy Journal of Tropical Pediatrics. ,vol. 51, pp. 109- 113 ,(2005) , 10.1093/TROPEJ/FMH095
Rachel Halpern, Patrick Gillard, Glenn D. Graham, Sepideh F. Varon, Richard D. Zorowitz, Adherence associated with oral medications in the treatment of spasticity. Pm&r. ,vol. 5, pp. 747- 756 ,(2013) , 10.1016/J.PMRJ.2013.04.022
Anna Mathew, M. C. Mathew, Bedtime diazepam enhances well-being in children with spastic cerebral palsy. Pediatric Rehabilitation. ,vol. 8, pp. 63- 66 ,(2005) , 10.1080/13638490410001731180
Roger Chou, Kim Peterson, Mark Helfand, Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review Journal of Pain and Symptom Management. ,vol. 28, pp. 140- 175 ,(2004) , 10.1016/J.JPAINSYMMAN.2004.05.002
Kimberly A. McKearnan, Gail M. Kieckhefer, Joyce M. Engel, Mark P. Jensen, Susan Labyak, Pain in children with cerebral palsy: a review. Journal of Neuroscience Nursing. ,vol. 36, pp. 252- 259 ,(2004) , 10.1097/01376517-200410000-00004